{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:38:06Z","timestamp":1794616686972,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was sponsored by Yangzhou City Science and Technology Project","award":["No.YZ2020159"],"award-info":[{"award-number":["No.YZ2020159"]}]},{"name":"This study was sponsored by Yangzhou City Science and Technology Project","award":["No.YZ2020159"],"award-info":[{"award-number":["No.YZ2020159"]}]},{"name":"This study was sponsored by Yangzhou City Science and Technology Project","award":["No.YZ2020159"],"award-info":[{"award-number":["No.YZ2020159"]}]},{"name":"This study was sponsored by Yangzhou City Science and Technology Project","award":["No.YZ2020159"],"award-info":[{"award-number":["No.YZ2020159"]}]},{"name":"This study was sponsored by Yangzhou City Science and Technology Project","award":["No.YZ2020159"],"award-info":[{"award-number":["No.YZ2020159"]}]},{"name":"This study was sponsored by Yangzhou City Science and Technology Project","award":["No.YZ2020159"],"award-info":[{"award-number":["No.YZ2020159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the efficacy of inflammatory markers (NLR, PLR) combined with tumor markers (CA50, CA199, CEA) in the diagnosis of colorectal cancer metastasis by a single-center retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1163 CRC patients who received treatments in our hospital from January 2017 to December 2021 were enrolled retrospectively. Patients were grouped according to the absence of metastasis. The separate efficacy of tumor markers, NLR and PLR, was evaluated in the diagnosis of metastasis of colorectal cancer using ROC curve analysis, and their optimal cut-off values for distant metastases from colorectal cancer were determined. The area under the ROC curve (AUC) of the tumor markers combined with NLR and PLR was calculated by binary logistic regression analysis to evaluate the diagnostic efficacy of metastasis of colorectal cancer. In addition, patients were divided into two groups of high and low levels according to the optimal cut-off values, and the effects of NLR, PLR, and tumor markers on distant metastasis of colorectal cancer were evaluated using multiple logistic regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      The abnormal rate of CA50, CA199, CEA, NLR, and PLR in two subgroupsIt was statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05). After AUC testifying, the diagnostic efficacy of NLR and PLR was equivalent to that of tumor marker (\n                      <jats:italic>P<\/jats:italic>\n                      &gt; 0.05). In assessment of liver metastasis, peritoneal metastasis, and multiple metastasis, AUC of NLR and PLR with CRC-specific tumor markers showed higher predictive efficacy than AUC without combined NLR nor PLR. The CA50, CA199, CEA, PLR, and NLR were proved independently associated with metastasis using multiple logistic regression analysis (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NLR and PLR are noted tumor markers of colorectal cancer, which are characterized by noninvasive, high diagnostic efficacy, easy availability, and low cost. They can be combined with traditional tumor markers to evaluate and diagnose colorectal cancer metastasis by clinicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-023-03108-4","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T22:01:37Z","timestamp":1690495297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of multiple biological indicators for the combined diagnosis of metastases from colorectal cancer\u2014a retrospective study based on 1163 patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Bangquan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"3108_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. \nhttps:\/\/doi.org\/10.3322\/caac.21660.\npublished Online First: 2021\/02\/05.","DOI":"10.3322\/caac.21660"},{"issue":"5","key":"3108_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","volume":"32","author":"LG van der Geest","year":"2015","unstructured":"van der Geest LG, Lam-Boer J, Koopman M, et al. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metas. 2015;32(5):457\u201365. https:\/\/doi.org\/10.1007\/s10585-015-9719-0. publishedOnlineFirst:2015\/04\/23.","journal-title":"Clin Exp Metas"},{"key":"3108_CR3","doi-asserted-by":"publisher","unstructured":"Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354. \nhttps:\/\/doi.org\/10.3322\/caac.21772.\npublished Online First: 2023\/03\/02.","DOI":"10.3322\/caac.21772"},{"key":"3108_CR4","doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2021;19(3):329\u201359. https:\/\/doi.org\/10.6004\/jnccn.2021.0012. published Online First: 2021\/03\/17.","DOI":"10.6004\/jnccn.2021.0012"},{"issue":"1","key":"3108_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059. publishedOnlineFirst:2022\/01\/14.","journal-title":"Cancer Discov"},{"issue":"11","key":"3108_CR6","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/s1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-503. https:\/\/doi.org\/10.1016\/s1470-2045(14)70263-3. publishedOnlineFirst:2014\/10\/05.","journal-title":"Lancet Oncol"},{"key":"3108_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.purol.2022.12.007","author":"N Kalfazade","year":"2023","unstructured":"Kalfazade N, \u00d6zl\u00fc DN, Sam E, et al. Factors associated with pathological tumor stage and T3a upstage in clinical T1\u20132 renal cell carcinoma. Prog Urol. 2023. https:\/\/doi.org\/10.1016\/j.purol.2022.12.007. publishedOnlineFirst:2023\/01\/06.","journal-title":"Prog Urol"},{"issue":"28","key":"3108_CR8","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.2217\/fon-2022-0607","volume":"18","author":"S Liang","year":"2022","unstructured":"Liang S, Wang B, Liu H, et al. Combined fibrinogen and neutrophil-lymphocyte ratio as a biomarker in predicting recurrence of giant cell tumor of bone. Future Oncol. 2022;18(28):3191\u20137. https:\/\/doi.org\/10.2217\/fon-2022-0607. publishedOnlineFirst:2022\/08\/25.","journal-title":"Future Oncol"},{"issue":"1","key":"3108_CR9","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1038\/s41598-022-14379-4","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang X, Li W, et al. Predictive value of neutrophil-to-lymphocyte ratio for distant metastasis in gastric cancer patients. Sci Rep. 2022;12(1):10269. https:\/\/doi.org\/10.1038\/s41598-022-14379-4. publishedOnlineFirst:2022\/06\/18.","journal-title":"Sci Rep"},{"key":"3108_CR10","doi-asserted-by":"publisher","unstructured":"Maloney S, Pavlakis N, Itchins M, et al. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) as biomarkers in resected pancreatic cancer. J Clin Med. 2023;12(5). https:\/\/doi.org\/10.3390\/jcm12051989. published Online First: 2023\/03\/12.","DOI":"10.3390\/jcm12051989"},{"key":"3108_CR11","doi-asserted-by":"publisher","unstructured":"Hernandez-Ainsa M, Velamazan R, Lanas A, et al. Blood-cell-based inflammatory markers as a useful tool for early diagnosis in colorectal cancer. Front Med. 2022;9:843074. https:\/\/doi.org\/10.3389\/fmed.2022.843074. published Online First: 2022\/07\/08.","DOI":"10.3389\/fmed.2022.843074"},{"key":"3108_CR12","doi-asserted-by":"publisher","first-page":"4889616","DOI":"10.1155\/2022\/4889616","volume":"2022","author":"XC Liu","year":"2022","unstructured":"Liu XC, Dai YL, Huang F, et al. Diagnostic value of carcinoembryonic antigen combined with multi-inflammatory cell ratios in colorectal cancer. Dis Markers. 2022;2022:4889616. https:\/\/doi.org\/10.1155\/2022\/4889616. publishedOnlineFirst:2022\/09\/06.","journal-title":"Dis Markers"},{"issue":"12","key":"3108_CR13","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.3390\/curroncol29120745","volume":"29","author":"S Salciccia","year":"2022","unstructured":"Salciccia S, Frisenda M, Bevilacqua G, et al. Comparative prospective and longitudinal analysis on the platelet-to-lymphocyte, neutrophil-to-lymphocyte, and albumin-to-globulin ratio in patients with non-metastatic and metastatic prostate cancer. Current oncology (Toronto, Ont). 2022;29(12):9474\u2013500. https:\/\/doi.org\/10.3390\/curroncol29120745. publishedOnlineFirst:2022\/12\/23.","journal-title":"Current oncology (Toronto, Ont)"},{"key":"3108_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.11.011","author":"H Yilmaz","year":"2022","unstructured":"Yilmaz H, Cinar NB, Avci IE, et al. The systemic inflammation response index: an independent predictive factor for survival outcomes of bladder cancer stronger than other inflammatory markers. Urol Oncol. 2022. https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.011. publishedOnlineFirst:2022\/12\/29.","journal-title":"Urol Oncol"},{"issue":"1","key":"3108_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12935-023-02876-z","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Xu T, Wang X, et al. The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis. Cancer Cell Int. 2023;23(1):39. https:\/\/doi.org\/10.1186\/s12935-023-02876-z. publishedOnlineFirst:2023\/03\/02.","journal-title":"Cancer Cell Int"},{"issue":"1\u20132","key":"3108_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0167-5877(00)00115-x","volume":"45","author":"M Greiner","year":"2000","unstructured":"Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000;45(1\u20132):23\u201341. https:\/\/doi.org\/10.1016\/s0167-5877(00)00115-x. publishedOnlineFirst:2000\/05\/10.","journal-title":"Prev Vet Med"},{"issue":"23","key":"3108_CR17","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/sim.5328","volume":"31","author":"OV Demler","year":"2012","unstructured":"Demler OV, Pencina MJ, D\u2019Agostino RB Sr. Misuse of DeLong test to compare AUCs for nested models. Stat Med. 2012;31(23):2577\u201387. https:\/\/doi.org\/10.1002\/sim.5328. publishedOnlineFirst:2012\/03\/15.","journal-title":"Stat Med"},{"key":"3108_CR18","volume-title":"Lemeshow S, Sturdivant RX","author":"DW Hosmer Jr","year":"2013","unstructured":"Hosmer DW Jr. Lemeshow S, Sturdivant RX. Applied logistic regression: John Wiley & Sons; 2013."},{"issue":"6917","key":"3108_CR19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137. https:\/\/doi.org\/10.1038\/nature01322. publishedOnlineFirst:2002\/12\/20.","journal-title":"Nature"},{"key":"3108_CR20","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.2147\/cmar.S177320","volume":"10","author":"Y Chen","year":"2018","unstructured":"Chen Y, Wang W, Zhang X, et al. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer. Cancer Manage Res. 2018;10:5411\u201322. https:\/\/doi.org\/10.2147\/cmar.S177320. publishedOnlineFirst:2018\/12\/07.","journal-title":"Cancer Manage Res"},{"issue":"1","key":"3108_CR21","doi-asserted-by":"publisher","first-page":"14662","DOI":"10.1038\/s41598-021-94184-7","volume":"11","author":"AB Sahin","year":"2021","unstructured":"Sahin AB, Cubukcu E, Ocak B, et al. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Sci Rep. 2021;11(1):14662. https:\/\/doi.org\/10.1038\/s41598-021-94184-7. publishedOnlineFirst:2021\/07\/21.","journal-title":"Sci Rep"},{"key":"3108_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2172-11-19","volume":"11","author":"V Deschoolmeester","year":"2010","unstructured":"Deschoolmeester V, Baay M, Van Marck E, et al. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol. 2010;11:19. https:\/\/doi.org\/10.1186\/1471-2172-11-19. publishedOnlineFirst:2010\/04\/14.","journal-title":"BMC Immunol"},{"issue":"8","key":"3108_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/jcp.24539","volume":"229","author":"D Sharma","year":"2014","unstructured":"Sharma D, Brummel-Ziedins KE, Bouchard BA, et al. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014;229(8):1005\u201315. https:\/\/doi.org\/10.1002\/jcp.24539. publishedOnlineFirst:2014\/01\/01.","journal-title":"J Cell Physiol"},{"issue":"7","key":"3108_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","volume":"143","author":"P Jurasz","year":"2004","unstructured":"Jurasz P, Alonso-Escolano D, Radomski MW. Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol. 2004;143(7):819\u201326. https:\/\/doi.org\/10.1038\/sj.bjp.0706013. publishedOnlineFirst:2004\/10\/20.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3108_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"JL Ethier","year":"2017","unstructured":"Ethier JL, Desautels D, Templeton A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2. https:\/\/doi.org\/10.1186\/s13058-016-0794-1. publishedOnlineFirst:2017\/01\/07.","journal-title":"Breast Cancer Res"},{"key":"3108_CR26","doi-asserted-by":"publisher","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. \nhttps:\/\/doi.org\/10.1093\/jnci\/dju124. published Online First: 2014\/05\/31.","DOI":"10.1093\/jnci\/dju124"},{"key":"3108_CR27","doi-asserted-by":"publisher","unstructured":"Minici R, Siciliano MA, Ammendola M, et al. Prognostic role of neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-C reactive protein ratio (LCR) in patients with hepatocellular carcinoma (HCC) undergoing chemoembolizations (TACE) of the liver: the unexplored corner linking tumor microenvironment, biomarkers and interventional radiology. Cancers. 2022;15(1). https:\/\/doi.org\/10.3390\/cancers15010257. published Online First: 2023\/01\/09.","DOI":"10.3390\/cancers15010257"},{"key":"3108_CR28","doi-asserted-by":"publisher","unstructured":"Wang W, Tong Y, Sun S, et al. Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer. Front Oncol. 2022;12:936206. https:\/\/doi.org\/10.3389\/fonc.2022.936206. published Online First: 2022\/09\/17.","DOI":"10.3389\/fonc.2022.936206"},{"key":"3108_CR29","doi-asserted-by":"publisher","first-page":"7971415","DOI":"10.1155\/2022\/7971415","volume":"2022","author":"W Chen","year":"2022","unstructured":"Chen W, Xin S, Xu B. Value research of NLR, PLR, and RDW in prognostic assessment of patients with colorectal cancer. J Healthcare Eng. 2022;2022:7971415. https:\/\/doi.org\/10.1155\/2022\/7971415. publishedOnlineFirst:2022\/04\/27.","journal-title":"J Healthcare Eng"},{"key":"3108_CR30","doi-asserted-by":"publisher","unstructured":"Lin Z, Zhang X, Luo Y, et al. The value of hemoglobin-to-red blood cell distribution width ratio (Hb\/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer. Medicine. 2021;100(28):e26537. https:\/\/doi.org\/10.1097\/md.0000000000026537. published Online First: 2021\/07\/15.","DOI":"10.1097\/md.0000000000026537"},{"issue":"2","key":"3108_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.21037\/tlcr-20-997","volume":"10","author":"C Chen","year":"2021","unstructured":"Chen C, Yang H, Cai D, et al. Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer. Transl Lung Cancer Res. 2021;10(2):866\u201377. https:\/\/doi.org\/10.21037\/tlcr-20-997. publishedOnlineFirst:2021\/03\/16.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"3108_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12894-020-00628-z","volume":"20","author":"C Hu","year":"2020","unstructured":"Hu C, Bai Y, Li J, et al. Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer. BMC Urol. 2020;20(1):57. https:\/\/doi.org\/10.1186\/s12894-020-00628-z. publishedOnlineFirst:2020\/05\/29.","journal-title":"BMC Urol"},{"issue":"5","key":"3108_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000497184","volume":"96","author":"T Aoyama","year":"2019","unstructured":"Aoyama T, Takano M, Miyamoto M, et al. Pretreatment neutrophil-to-lymphocyte ratio was a predictor of lymph node metastasis in endometrial cancer patients. Oncology. 2019;96(5):259\u201367. https:\/\/doi.org\/10.1159\/000497184. publishedOnlineFirst:2019\/03\/21.","journal-title":"Oncology"},{"issue":"4","key":"3108_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jso.24521","volume":"115","author":"D D'Andrea","year":"2017","unstructured":"D\u2019Andrea D, Moschini M, Gust KM, et al. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. J Surg Oncol. 2017;115(4):455\u201361. https:\/\/doi.org\/10.1002\/jso.24521. publishedOnlineFirst:2017\/01\/21.","journal-title":"J Surg Oncol"},{"issue":"6","key":"3108_CR35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.amjsurg.2021.10.026","volume":"223","author":"C Tong","year":"2022","unstructured":"Tong C, Wang W, Xia Y, et al. A potential novel biomarker in predicting lymph node metastasis of gastric signet ring cell carcinoma: a derived monocyte to lymphocyte ratio. Am J Surg. 2022;223(6):1144\u201350. https:\/\/doi.org\/10.1016\/j.amjsurg.2021.10.026. publishedOnlineFirst:2021\/10\/28.","journal-title":"Am J Surg"},{"issue":"9","key":"3108_CR36","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","volume":"21","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Hu ZG, Shi WX, et al. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21(9):2807\u201315. https:\/\/doi.org\/10.3748\/wjg.v21.i9.2807. publishedOnlineFirst:2015\/03\/12.","journal-title":"World J Gastroenterol"},{"key":"3108_CR37","doi-asserted-by":"publisher","unstructured":"Zanoni DK, Valero C, McGill MR, et al. Distant metastasis in oral squamous cell carcinoma: does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status? Oral Oncol. 2022;124:105641. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105641. published Online First: 2021\/12\/06.","DOI":"10.1016\/j.oraloncology.2021.105641"},{"key":"3108_CR38","doi-asserted-by":"publisher","unstructured":"Tao L, Zhang L, Peng Y, et al. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: a new hypothesis and a new predictor for distant metastasis. Medicine. 2016;95(39):e4932. \nhttps:\/\/doi.org\/10.1097\/md.0000000000004932. published Online First: 2016\/09\/30.","DOI":"10.1097\/md.0000000000004932"},{"issue":"1","key":"3108_CR39","doi-asserted-by":"publisher","first-page":"21180","DOI":"10.1038\/s41598-020-78253-x","volume":"10","author":"HS Park","year":"2020","unstructured":"Park HS, Chun YJ, Kim HS, et al. Clinical features and KRAS mutation in colorectal cancer with bone metastasis. Sci Rep. 2020;10(1):21180. https:\/\/doi.org\/10.1038\/s41598-020-78253-x. publishedOnlineFirst:2020\/12\/05.","journal-title":"Sci Rep"},{"key":"3108_CR40","doi-asserted-by":"publisher","unstructured":"Qian Y, Li Y, Fu Y. A commentary on \u201cPrognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: a meta-analysis of results from multivariate analysis\u201d. Int J Surg. 2023. https:\/\/doi.org\/10.1097\/js9.0000000000000531. published Online First: 2023\/06\/15.","DOI":"10.1097\/js9.0000000000000531"},{"issue":"1","key":"3108_CR41","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1038\/s41598-018-21048-y","volume":"8","author":"Y Gao","year":"2018","unstructured":"Gao Y, Wang J, Zhou Y, et al. Evaluation of serum CEA, CA19-9, CA72-4, CA125 and Ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep. 2018;8(1):2732. https:\/\/doi.org\/10.1038\/s41598-018-21048-y. publishedOnlineFirst:2018\/02\/11.","journal-title":"Sci Rep"},{"issue":"1","key":"3108_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12957-022-02874-x","volume":"20","author":"HQ Zhu","year":"2022","unstructured":"Zhu HQ, Wang DY, Xu LS, et al. Diagnostic value of an enhanced MRI combined with serum CEA, CA19-9, CA125 and CA72-4 in the liver metastasis of colorectal cancer. World journal of surgical oncology. 2022;20(1):401. https:\/\/doi.org\/10.1186\/s12957-022-02874-x. publishedOnlineFirst:2022\/12\/19.","journal-title":"World journal of surgical oncology"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03108-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T22:05:56Z","timestamp":1690495556000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3108"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03108-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Northern Jiangsu People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}